Blood pressure assessment, treatment and control for primary prevention of cardiovascular disease in patients with and without depression
E Ellins,R Summers,A Akbari,K Lloyd,D Osborn,A John,M Gravenor,J Halcox
DOI: https://doi.org/10.1093/eurjpc/zwae175.341
IF: 8.526
2024-06-01
European Journal of Preventive Cardiology
Abstract:Abstract Background Patients with depression are at increased risk of future cardiovascular disease (CVD) events compared to those without depression. The reasons for this are not fully understood. Appropriate management of CVD risk factors, including blood pressure (BP) are essential for primary prevention of CVD. Purpose To explore whether there are differences in the likelihood of assessment, treatment and attainment of target levels of BP in patients with depression compared to those without. Methods A retrospective observational cohort study of patients without a history of depression or CVD was conducted using individual-level linked electronic health record data between 2010 & 2019 using the all-Wales SAIL Databank. Clinical codes were used to identify depression and hypertension diagnoses, BP assessments and antihypertensive therapy (AHT) from general practice (GP) data. Blood pressure assessment is presented as person year rates, and logistic regression was used to identify the likelihood of treatment and control of BP (<140/<90mmHg). Results A total of 2,290,075 patients were included (47% female & 7.7% depressed). Depressed patients were younger than non-depressed (mean age 32.0±15.5 vs 40.7±19.3 yrs respectively). Blood pressure assessment rates (BP checks per person per year) were greater in patients with depression 0.813 (0.811-0.815) vs 0.621 (0.620-0.621). Assessment was most frequent in depressed women (0.988 [0.985-0.991]) and least in non-depressed males (0.490 [0.489-0.490]). In patients with a history of HTN, GP diagnosis or high BP reading (n=738,164), 265,232 (35.9%) were on AHT within one year; a smaller proportion of depressed patients with hypertension were receiving AHT than non-depressed (23,808 [34.0%] vs 241,424 [36.1%] p<0.001). However, after multiple logistic regression (adjusting for age, sex, location of residence, deprivation, and comorbidities), depressed patients were more likely to be on AHT (OR 1.22 95%CI 0.12-1.32). In those patients on AHT 235,134 (88.7%) had at least one valid BP measurement during the year. Of these 114,601 (48.7%) achieved a BP <140/90 mmHg. A greater proportion of depressed patients with hypertension on AHT had documented control of BP than non-depressed (11,143 [57.3%] vs 103,458 [48.0%] p<0.001 OR 1.28 95%CI 1.11-1.50). There was a significant interaction between depression and sex, with depressed females being the most likely to achieve control (p<0.001). Conclusion Patients with depression are more likely to have BP assessed and to have hypertension treated and controlled than patients without depression within Welsh primary care. This maybe due to more frequent interaction with their GP, but further research is required to investigate reasons and impact on outcomes.
cardiac & cardiovascular systems